The National Institute for Health and Care Excellence

Hundreds of people set to benefit after life-extending lung cancer treatment given green light

Targeted immunotherapy found to significantly increase overall survival rates for people with an aggressive form of lung cancer has been recommended by NICE. People with an aggressive form of lung ...
The National Institute for Health and Care Excellence

Our first guideline on kidney cancer recommends better use of biopsies to avoid surgery

The NICE guideline recommends offering a biopsy to help confirm the diagnosis and inform treatment options for people with suspected renal cell carcinoma (RCC), where the cancer has not spread (known ...
National Institute for Health and Care Excellence

Multiple sclerosis in adults: management

This guidance has been updated and replaced by multiple sclerosis in adults: management ...
National Institute for Health and Care Excellence

Published guidance, NICE advice and quality standards

Pneumonia: diagnosis and management QS110 19 January 2016 2 September 2025 Pneumonia: diagnosis and management NG250 2 September 2025 2 September 2025 Suspected acute respiratory infection in over 16s ...
The National Institute for Health and Care Excellence

Fertility clinics must end unproven treatments that don't help couples have babies

Fertility clinics should not offer unproven treatments that don't help people have babies, our independent committee has recommended in draft guidance.
National Institute for Health and Care Excellence

Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies

Guidance Standards and indicators Clinical Knowledge Summaries (CKS) British National Formulary (BNF) British National Formulary for Children (BNFC) Life sciences Library and knowledge services What ...
National Institute for Health and Care Excellence

Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency

Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency Technology appraisal guidance ...
National Institute for Health and Care Excellence

Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer

Guidance Standards and indicators Clinical Knowledge Summaries (CKS) British National Formulary (BNF) British National Formulary for Children (BNFC) Life sciences Library and knowledge services What ...
National Institute for Health and Care Excellence

Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection

Guidance Standards and indicators Clinical Knowledge Summaries (CKS) British National Formulary (BNF) British National Formulary for Children (BNFC) Life sciences Library and knowledge services What ...
National Institute for Health and Care Excellence

COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19

This guideline has been updated and replaced by NICE rapid guideline on managing COVID-19 (NG191) ...
National Institute for Health and Care Excellence

Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy

Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy Technology appraisal ...
National Institute for Health and Care Excellence

COVID-19 rapid guideline: severe asthma

May 2022: This guideline has been withdrawn because current practice is to manage COVID-19 risk in line with risk of other respiratory infections. See our guidance on treating severe asthma and our ...